’  ’ ”   We’re getting closer to finding out who will be running the Food   and Drug Administration under President Donald Trump. ” ’   Multiple outlets have reported that Dr. Scott Gottlieb is   expected to be nominated as the commissioner of the FDA,   with an official nod coming as early as Friday.  ’ ”   Gottlieb, a resident fellow at the American Enterprise Institute   and venture partner at New Enterprise Associates. He   previously served as former deputy commissioner of the FDA   during George W. Bush’s presidency. ” ’   Trump has said that he wants to deregulate the drug industry,   which the FDA regulates, and has called the   process   ”slow and burdensome.” ’ ’   ”We’’re going to be cutting regulations at a level that nobody’’s   ever seen before,” Trump said in a meeting with drug   company executives on January 31. He estimated up to 80% of   regulations would be slashed. ’ ’’ ”   Over the years, Gottlieb has been vocal about his thoughts on the   FDA. Here’s what that could mean for the future of the   agency.  ” ’   Gottlieb emerged early on as a favorite among members of the drug   industry. Salim Syed, a biotech analyst at Mizuho, asked   pharma executives who they would like to see as the next FDA   commissioner. The overwhelming majority (72%) said   Gottlieb.  ’ ’  ’ ”   The FDA is responsible for regulating food and drugs. It’s also   responsible for regulating medical devices, blood donations,   veterinary products, cosmetics, and tobacco. Trump’s comments   have left the drug industry  what deregulation could mean for the     process. ” ’   It was  when the Food and Drugs Act was   signed into law, prohibiting misbranded food, drinks, and drugs   from interstate commerce. This cracked down on misleading claims   that treatments could ”cure” patients. ’ ’   Here are some examples of the FDA at work: ’ ”We’re getting closer to finding out who will be. ..” ’’ ’’ ’’